311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with a prevalence up to 30%. NAFLD is strongly associated with components of metabolic syndrome, already recognized as risk factors for worse outcomes in COVID-19. However, the impact of NAFLD on COVID-19 is not w...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrsaljko, Nina, Samadan, Lara, Budimir, Jelena, Topic, Mirjana Balen, Kurelac, Ivan, Vince, Adriana, Papić, Neven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644783/
http://dx.doi.org/10.1093/ofid/ofab466.513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644783/
http://dx.doi.org/10.1093/ofid/ofab466.513

Ejemplares similares